# Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform

> **NCT00247299** · NA · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 30 (—)

## Conditions studied

- Telangiectases
- Port Wine Stain

## Interventions

- **DEVICE:** IPL Quantum Product manufactured by Luminis Ltd.

## Key facts

- **NCT ID:** NCT00247299
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247299, "Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00247299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*